We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Microsaic Systems Plc | LSE:MSYS | London | Ordinary Share | GB00BMWC8365 | ORD GBP0.00001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.025 | -2.50% | 0.975 | 0.95 | 1.00 | 1.00 | 0.975 | 1.00 | 2,186,520 | 09:31:47 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Components, Nec | 1.57M | -2.29M | -0.0128 | -0.76 | 1.74M |
Date | Subject | Author | Discuss |
---|---|---|---|
03/11/2023 13:53 | There’s your answer. They could at least have saved that news until Christmas Eve. Shame on them. | mr macgregor | |
27/9/2023 08:55 | Any thoughts on how they are going to raise funds? Rights or placing? | pwal | |
25/9/2023 07:17 | Well, the Leprechaun has gone to pursue other interest, pmsl. More like no company will be able to get funds whilst he is in control! | cocker | |
30/6/2023 09:46 | Soul, the man is a complete and utter conman who's plan was to mug investors and to fill his pockets with their dollars all along. His blatant behaviour was brushed under the carpet by so many, even when faced with facts like "no funding needed" & yet less then 6 weeks later he asked for 2 million. Buying up related companies and pocketing over 100k and still investors believed him over someone who pointed out how wrong things were. Unfortunately investors have lost millions between them and yet he will walk away scott free! | cocker | |
30/6/2023 08:30 | One perhaps would suggest GB maybe is still telling some penny punt morons that there's value to be had, can any sane person have a genuine reason to be buying | cocker | |
29/6/2023 16:21 | DVRG now MSYS - | tomboyb | |
29/6/2023 16:02 | TIDMMSYS RNS Number : 4384E Microsaic Systems plc 29 June 2023 29 June 2023 Microsaic Systems plc ("Microsaic" or the "Company") FY22 Annual Report and Accounts Further to the Company's announcement on 26 June 2023 (the "Prior Announcement"), the Board of Microsaic (AIM: MSYS) now confirms that the Company's annual report and accounts for the year ended 31 December 2022 ("FY22") will not be published by 30 June 2023, being the deadline for publication under the AIM Rules for Companies. Consequently, the Company's shares will be suspended from trading on AIM with effect from 3 July 2023, pending publication of the FY22 annual report and accounts. The Board noted in the Prior Announcement that, as of 31 May 2023, Microsaic had GBP0.65m in cash and on deposit, with no bank borrowings. The Company also stated that it continues to meet its obligations as they fall due. In light of the challenges associated with making further recovery of the outstanding debtor balance from DeepVerge plc, and that the conversion of its growing pipeline and the speed and scale of revenue generation are uncertain, the Prior Announcement noted that it was likely that Microsaic will need to raise further working capital during Q3 2023. The Company confirms that it is working to that end and intends to conclude a fundraising within that period, and to seek reinstatement of its shares to trading on AIM shortly aftewards, subject also to having published the FY22 report and accounts on a going concern basis. Such fundraising is likely to be subject to shareholder approval to issue and allot new shares. Further announcements will be made as appropriate. | tomboyb | |
29/6/2023 16:02 | Suspension coming - RNS - Delay - | tomboyb | |
26/6/2023 22:05 | Zxie recent post 30mill and loading. PMSL | cocker | |
26/6/2023 09:19 | Given history and management how likely is it that they will be able to raise funds? Do their products have any must buy USP'a. or What might the company be worth to a scalper? or anyone with a flat in Kensington prepared to take out a mortgage and buy the company? Only £750K (if ADVFN MC correct) and take private - Look what you would save on listing and brokers charges!! and £650K in cash - but burn rate unknown - | pugugly | |
26/6/2023 07:38 | Did GB have a past? He's basically destroyed 2 companies and robbed all the shareholders! | scalpface | |
21/6/2023 13:18 | So:Microsaic has a growing sales pipeline currently worth in excess of GBP2 milllion, over 90% of which is from customers or distribution channels other than DeepVerge.Hopefully next week's results will be favourable and positive. Smiley face. | pwal | |
15/6/2023 14:36 | Looks like the big boys escaping whilst they can! | cocker | |
12/6/2023 12:05 | So results on or before 30th June.Not long now. | pwal | |
23/5/2023 17:48 | 30m loading | zxie | |
22/5/2023 14:55 | Audit delay possibly done to allow mates to exit before the final curtain comes down!. You don't have to be Einstein to see the big trades flying through whilst penny punters pick up the stock, what is surprising is how well the share price has done considering the amounts being dumped. | cocker | |
17/5/2023 19:34 | Everything GB touches, lol | owenski | |
17/5/2023 19:13 | looks like GB trying to offload all his shares with TP as well. Maybe they will bid for DVRG LOL. Expect any holders here will be selling and moving on as now 'a dead duck' | onehanded | |
17/5/2023 17:29 | That's why I got out. Should be locked up in my opinion. | alancapone | |
17/5/2023 17:18 | 15 May '23 - 11:40 - 1101 of 1107 0 4 1 Firstly, the claim that "the product just isn't strong enough" is not supported by the fact that Microsaic Systems has successfully sold its instruments to several clients, including multinational corporations like Pfizer and AstraZeneca, as well as government institutions like the UK's National Health Service (NHS). How many have the sold? less than 10 a year? Total sales since I posted the above about 5 years ago are about £2.5m Loss that year alone was £2.8m so nowhere near enough Furthermore, the ongoing partnership with Avacta Group, a UK-based biotech company, shows that there is a potential for the technology to be used in high-throughput drug discovery, which can lead to substantial growth opportunities. It is also worth noting that the contract with Avacta is ongoing, which indicates that the partnership has been successful so far. In terms of revenue, although Microsaic Systems reported a revenue of £0.4 million in 2021, it is important to consider the fact that the company has only recently started commercializing its products. Its been 5 years since I posted the above. They also signed many distributor agreements - such as with Omicron in the UK. You can give them a ring and ask how many they sold (0). Regarding the claim that the company should delist and become a small service company, it is worth noting that the company has been actively expanding its product portfolio. For example, in 2021, Microsaic Systems announced the launch of its second product line, the 4500 MiD, which is a more advanced version of its previous product. This indicates that the company is still investing in product development and is not solely focused on becoming a service company. Yes, but their is no evidence these will sell either. In terms of the claim that Microsaic's technology is not game-changing, it is important to note that the company's instruments offer advantages such as portability and speed, which are not found in traditional LC/MS systems. These advantages make the technology appealing to a variety of clients, particularly those in the pharmaceutical and biotech industries. Portability offers no benefits to the pharmaceutical industry. In a pharma lab every piece of equipment has to be qualified to show its working as it should. If a piece of equipment is moved, even from one bench to another it needs to be requalified (it takes a day and cost about £1k). The samples go to the lab, the lab doesn't go to the sample. May be some use monitoring river water etc, but I don't work in that area. Overall, while there are challenges facing Microsaic Systems, such as competition from established players in the industry, there is evidence to suggest that the company has the potential for growth and success in the future. .................... Unimicro Technologies Inc.: In 2018, Microsaic signed an agreement with Unimicro Technologies Inc., a Chinese distributor of scientific equipment. Under the agreement, Unimicro became Microsaic's exclusive distributor for the MiD product line in China, Hong Kong, and Taiwan. The agreement has a three-year term with an option to extend for a further two years. Avacta Group plc: In 2019, Microsaic signed an agreement with Avacta Group plc, a UK-based biotech company. Under the agreement, Microsaic's mass spectrometry technology is integrated with Avacta's Affimer reagents to develop a high-throughput screening platform for drug discovery. The collaboration is ongoing as of 2021. Process Instruments & Components, Inc.: In 2021, Microsaic announced a distribution agreement with Process Instruments & Components, Inc., a US-based distributor of scientific equipment. Under the agreement, Process Instruments & Components became Microsaic's exclusive distributor for the MiD product line in the United States. The agreement has an initial term of two years. Waters Corporation: In 2016, Microsaic signed a collaboration agreement with Waters Corporation, a US-based manufacturer of analytical instruments. Under the agreement, Microsaic's technology was integrated with Waters' mass spectrometry systems to provide a high-throughput solution for drug discovery. The collaboration ended in 2019. Green Energy Technology Inc.: In 2016, Microsaic signed a distribution agreement with Green Energy Technology Inc., a Taiwanese distributor of scientific equipment. Under the agreement, Green Energy became Microsaic's exclusive distributor for the MiD product line in Taiwan. The agreement ended in 2018. Why did so many of these agreements end? Because they couldn't sell it. Anyway I'll leave you all to it. | dr biotech |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions